Distribution of genetic variants in preneoplastic areas of colorectal tumours

European Journal of Surgical Oncology

Volumn 29, Issue 6, 2003, Pages 491-496

  Lindforss, Ulrik ^a   Papadogiannakis, N ^a   Zetterquist, H ^a   Lindberg, G ^a   Olivecrona, H ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Colorectal carcinoma; Heterogeneity; K ras mutations; LOH chromosome 17p; LOH chromosome 18q; LOH chromosome 5q; Loss of heterozygosity

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER TISSUE; CARCINOGENESIS; CELL CLONE; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ACTIVITY; DNA DETERMINATION; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC STABILITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROSATELLITE MARKER; ONCOGENE K RAS; POINT MUTATION; PRECANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; TISSUE FIXATION; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 0041475732     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00075-1     Document Type: Article

References (51)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49(1): 33-64.
2. Moertel CG et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 1995; 13(12): 2936-43.
3. Riethmuller G et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 1998; 16(5): 1788-94.
4. Dahlberg M, Glimelius B, Pahlman L. Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish rectal cancer trial. Ann Surg 1999; 229(4): 493-7.
5. Iino H et al. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994; 73(5): 1324-31.
6. Aaltonen LA. The multistep process of colon carcinogenesis. Cytokines Mol Ther 1996; 2(2): 111-4.
7. Jernvall P et al. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J Cancer 1999; 79(5-6): 903-8.
8. Zauber NP et al. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J Pathol 2001; 193(3): 303-9.
9. Saraga E et al. Genetic heterogeneity in sporadic colorectal adenomas. J Pathol 1997; 181(3): 281-6.
10. Thiagalingam S et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996; 13(3): 343-6.
11. Baisse B et al. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 2001; 93(3): 346-52.
12. Lindforss U et al. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 2000; 88(12): 2661-7.
13. Zhuang Z et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm size. Am J Pathol 1995; 146(3): 620-5.
14. Kuroda K et al. Analysis of genetic changes in progression of colorectal cancer. Gan To Kagaku Ryoho 1996; 23(Suppl. 2): 164-8.
15. Berney CR et al. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer 2000; 89(1): 1-7.
16. Chung DC. Molecular prognostic markers and colorectal cancer: the search goes on. Gastroenterology 1998; 114(6): 1330-2.
17. Jen J et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994; 331(4): 213-21.
18. Martinez-Lopez E et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998; 114(6): 1180-7.
19. Ogunbiyi OA et al. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 1998; 16(2): 427-33.
20. Sugai T et al. Allelic losses of 17p, 5q, and 18q loci in diploid and aneuploid populations of multiploid colorectal carcinomas. Hum Pathol 2000; 31(8): 925-30.
21. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5): 759-67.
22. Gao S, Xu W, Wan Y. Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential. Zhonghua Zhong Liu Za Zhi 1996; 18(4): 250-2.
23. Baker SJ et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50(23): 7717-22.
24. Chetty R, Naidoo R, Schneider J. Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology. Mol Pathol 1998; 51 (1): 35-8.
25. el Sebai H et al. Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations. Cancer Genet Cytogenet 1998; 104(1): 32-8.
26. Font A et al. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum 2001; 44(4): 549-57.
27. Glarakis IS, Savva S, Spandidos DA. Activation of the ras genes in malignant and premalignant colorectal tumors. Oncol Rep 1998; 5(6): 1451-4.
28. Fung C et al. K-ras mutation and loss of heterozygosity of chromosome 17p and survival in colorectal cancer. Aust N Z J Surg 1997; 67(5): 239-44.
29. Minamoto T et al. Combined analysis of microsatellite instability and K-ras mutation increases detection incidence of normal samples from colorectal cancer patients. Clin Cancer Res 1997; 3(8): 1413-7.
30. Ohnishi T et al. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma. Br J Cancer 1997; 75(3): 341-7.
31. Senagore AJ, Biener JT. A newly identified pattern of K-ras mutations at codons 12 and 13 is associated with long-term survival in colorectal cancer. Surgery 1997; 122(4): 765-70.
32. Tortola S et al. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer. J Clin Oncol 1999; 17(5): 1375-81.
33. Zauber NP et al. K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma. Cancer 1999; 86(1): 31-6.
34. Cawkwell L et al. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993; 67(6): 1262-7.
35. Riesner HS, Advances in Electrophoresis, vol. 4. Weinheim: VCH Verlagsgesellshaft, 1998: 169-250.
36. Bonferroni C. Teoria statistica della classi e calcolo della probabilit 'a. Pubblicazione del R Instituto Superiore de Scienze Economiche e commercial 1936.
37. Yamashita-N et al. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer 1995; 75(Suppl. 6): 1527-33.
38. Zhu D et al. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res 1997; 57(12): 2485-92.
39. Toth A, Harsanyi L, Szecseny A. Multiple primary malignant tumours of patients treated for colorectal carcinoma (clinical analysis of 61 cases). Acta Chir Hung 1989; 30(2): 163-9.
40. Koshiji M et al. Microsatellite analysis of fecal DNA for colorectal cancer detection. J Surg Oncol 2002; 80(1): 34-40.
41. Ito Y et al. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples. Int J Oncol 2002; 20(6): 1263-8.
42. Lecomte T et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer 2002; 100(5): 542-8.
43. Ajioka Y et al. Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum. Gut 1998; 42(5): 680-4.
44. Yashiro M et al. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 2001; 61(6): 2676-83.
45. Laurent-Puig P, Blons H, Cugnenc PH. Sequence of molecular genetic events in colorectal tumorigenesis. Eur J Cancer Prev 1999; 8(Suppl. 1): S39-S47.
46. Boland CR, Ricciardiello L. How many mutations does it take to make a tumor? Proc Natl Acad Sci USA 1999; 96(26): 14675-7.
47. Fiocca R. DCC changes and prognosis in colorectal carcinoma. Pathologica 1998; 90(1): 79-80.
48. Forslund A et al. Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma. J Clin Oncol 2001; 19(11): 2829-36.
49. Martin L, Assem M, Piard F. Are there several types of colorectal carcinomas? Correlations with genetic data. Eur J Cancer Prev 1999; 8(Suppl. 1): S13-S20.
50. Jacob S, Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 2002; 84(1): 27-47.
51. Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002; 3(2): 83-8.